Jeg klarte ikke å se noe delta der. Men jeg leste dette.
Filgotinib is an investigational agent and is not approved by the FDA or any other regulatory authority for any use. Regulatory submissions of filgotinib for the treatment of rheumatoid arthritis are currently under review by the FDA, European Medicines Agency, and Japan’s Ministry of Health, Labour and Welfare. The efficacy and safety of filgotinib have not been established. For information about the clinical trials with filgotinib: www.clinicaltrials.gov